Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 2
2010 1
2011 4
2012 5
2013 2
2014 7
2015 4
2016 4
2017 6
2018 6
2019 7
2020 11
2021 10
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Gandhy SU, Karzai FH, Bilusic M, McMahon S, Cordes LM, Marte J, Weisman AJ, Perk TG, Lindenberg L, Mena E, Turkbey B, Arlen PM, Dahut WL, Figg WD, Choyke P, Gulley JL, Madan RA. Gandhy SU, et al. Among authors: bilusic m. Eur Urol Oncol. 2023 Oct 17:S2588-9311(23)00205-5. doi: 10.1016/j.euo.2023.09.010. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37858437
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistance.
Zhang L, Troccoli CI, Mateo-Victoriano B, Lincheta LM, Jackson E, Shu P, Plastini T, Tao W, Kwon D, Chen X, Sharma J, Jorda M, Gulley JL, Bilusic M, Lockhart AC, Beuve A, Rai P. Zhang L, et al. Among authors: bilusic m. bioRxiv [Preprint]. 2023 May 3:2023.05.03.537252. doi: 10.1101/2023.05.03.537252. bioRxiv. 2023. PMID: 37205442 Free PMC article. Preprint.
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Madan RA, Bilusic M, Stein MN, Donahue RN, Arlen PM, Karzai F, Plimack E, Wong YN, Geynisman DM, Zibelman M, Mayer T, Strauss J, Chen G, Rauckhorst M, McMahon S, Couvillon A, Steinberg S, Figg WD, Dahut WL, Schlom J, Gulley JL. Madan RA, et al. Among authors: bilusic m. Oncologist. 2023 Jul 5;28(7):642-e561. doi: 10.1093/oncolo/oyad058. Oncologist. 2023. PMID: 37134294 Free PMC article. Clinical Trial.
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
Gatti-Mays ME, Tschernia NP, Strauss J, Madan RA, Karzai FH, Bilusic M, Redman J, Sater HA, Floudas CS, Toney NJ, Donahue RN, Jochems C, Marté JL, Francis D, McMahon S, Lamping E, Cordes L, Schlom J, Gulley JL. Gatti-Mays ME, et al. Among authors: bilusic m. Oncologist. 2023 Apr 6;28(4):364-e217. doi: 10.1093/oncolo/oyac244. Oncologist. 2023. PMID: 36640137 Free PMC article. Clinical Trial.
Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer.
Rich BJ, Montoya C, Jin WH, Spieler BO, Mahal BA, Delgadillo R, Bilusic M, Abramowitz MC, Pollack A, Dal Pra A. Rich BJ, et al. Among authors: bilusic m. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):718-724. doi: 10.1016/j.ijrobp.2022.05.040. Epub 2022 Jun 4. Int J Radiat Oncol Biol Phys. 2022. PMID: 35671868 No abstract available.
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Schmidt KT, Karzai F, Bilusic M, Cordes LM, Chau CH, Peer CJ, Wroblewski S, Huitema ADR, Schellens JHM, Gulley JL, Dahut WL, Figg WD, Madan RA. Schmidt KT, et al. Among authors: bilusic m. Oncologist. 2022 Sep 2;27(9):718-e694. doi: 10.1093/oncolo/oyac100. Oncologist. 2022. PMID: 35640474 Free PMC article. Clinical Trial.
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
Redman JM, Tsai YT, Weinberg BA, Donahue RN, Gandhy S, Gatti-Mays ME, Abdul Sater H, Bilusic M, Cordes LM, Steinberg SM, Marte JL, Jochems C, Kim SS, Marshall JL, McMahon S, Redmond E, Schlom J, Gulley JL, Strauss J. Redman JM, et al. Among authors: bilusic m. Oncologist. 2022 Mar 11;27(3):198-209. doi: 10.1093/oncolo/oyab046. Oncologist. 2022. PMID: 35274710 Free PMC article. Clinical Trial.
69 results